BioROSA Technologies
PrivateCompany Overview
BioROSA Technologies operates in Healthcare & Life Sciences and is based in Wayland, Massachusetts. It was founded in 2018.
BioROSA Technologies is a biotechnology company that develops a blood-based, metabolomics and machine learning platform for the early diagnosis and assessment of Autism Spectrum Disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioROSA Technologies Comparables
Compare BioROSA Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LinusBio | 84% | |
| iDiagnostix Ltd | 83% | |
| NeuroQure | 82% |
For institutional investors. Book with your work email.
BioROSA Technologies Funding Rounds
Historical fundraising activity
BioROSA Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioROSA Technologies's valuation, stock price, and market status.
Is BioROSA Technologies a public or private company?
BioROSA Technologies is a private company.
What is the current stock price of BioROSA Technologies?
BioROSA Technologies is a private company, so its shares have no public market price. Caplight tracks BioROSA Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioROSA Technologies worth (valuation)?
Valuation information for BioROSA Technologies is not publicly available.
Can I buy BioROSA Technologies stock?
BioROSA Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioROSA Technologies's last funding round?
Funding round information for BioROSA Technologies is not publicly available.
Who are the main investors in BioROSA Technologies?
Investor information for BioROSA Technologies is not publicly disclosed.
Will BioROSA Technologies IPO soon?
No public IPO plans have been announced for BioROSA Technologies.
How can I track BioROSA Technologies secondary market activity?
Caplight tracks bids, offers, and trades in BioROSA Technologies's shares on secondary markets.